RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis.
Zelic M, Pontarelli F, Woodworth L, Zhu C, Mahan A, Ren Y, LaMorte M, Gruber R, Keane A, Loring P, Guo L, Xia TH, Zhang B, Orning P, Lien E, Degterev A, Hammond T, Ofengeim D.
Zelic M, et al. Among authors: loring p.
Cell Rep. 2021 May 11;35(6):109112. doi: 10.1016/j.celrep.2021.109112.
Cell Rep. 2021.
PMID: 33979622
Free PMC article.